Agilent and Monash University Celebrate 15 Years with New BioDiscovery Hub

5 December 2025

KUALA LUMPUR: Agilent Technologies Inc. (NYSE: A) has announced the expansion of its strategic partnership with Monash University Malaysia to establish a cutting-edge BioDiscovery Hub at MUMPMP. This new facility aims to accelerate biotechnology research and innovation across the region. The agreement, signed in celebration of the partnership’s 15th anniversary, highlights Agilent’s ongoing commitment to advancing high-impact research and development in dynamic Asian markets.

Under the renewed collaboration, Agilent will supply its high-resolution Revident Quadrupole Time of Flight LC/MS systems, alongside the 1290 Infinity III High-Performance Liquid Chromatography series and the next-generation 5977C Gas Chromatography/Mass Spectrometry Detector. These technologies will support joint research projects, application development, workshops, and scientific training at the new hub. The partnership seeks to accelerate research in small- and large-molecule analysis, fostering deeper insights in biomedical, pharmaceutical, and molecular biology fields.

Dr. Syafiq Asnawi, Senior Lecturer in Biomedical Science and Director of the Department of Molecular Epidemiology & Translational Medicine and the MUM Proteomics & Metabolomics Platform, stated, “This collaboration exemplifies Monash Malaysia’s dedication to providing world-class research infrastructure that advances discovery and benefits our communities. The BioDiscovery Hub strengthens our leadership in proteomics, metabolomics, and biotechnology innovation. By combining Agilent’s advanced technologies with Monash’s research excellence and multidisciplinary ecosystem, we are empowering scientists and partners to develop impactful solutions for Malaysia and the wider Asia-Pacific region.”

Bharat Bhardwaj, Vice President of Sales for Asia Pacific at Agilent, added, “At Agilent, we are proud to support Monash University Malaysia in enhancing biological research through proteomics, metabolomics, and lipidomics. Our renewed partnership continues our 15-year collaboration and positions Agilent as a leader in biotechnology innovation. The BioDiscovery Hub will drive scientific progress, talent development, and create long-term value for our customers and partners.”

With over 25 years of presence in Malaysia, Agilent remains committed to contributing to the nation’s scientific advancement through collaborations between academia and industry, workforce development, and reinforcing Malaysia’s status as a regional hub for analytical and biotechnological innovation.